Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 10 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rational Design of a Potent, Selective, and Metabolically Stable CDK9 Inhibitor to Counteract Osimertinib Resistance Through Mcl-1 Suppression and Enhanced BRD4 Co-Targeting
Tizhi Wu, Jiali Huang, Xiankang Zhang,Feihai Ma, Shijing Yu, Yifang Liu, Yifan Xu, Shiqi Wu,Alexander V Finko,Zhiyu Li, Li Feng,Jinlei Bian
Journal of medicinal chemistryno. 4 (2025): 4929-4950
Cited0Views0WOSBibtex
0
0
Discovery and Optimization of Potent and Highly Selective PARP14 Inhibitors for the Treatment of Atopic Dermatitis
Shiqi Wu, Xiaorong Zeng, Jing Liu, Kaiyuan Cong, Shaoxue Lou, Ziyue Li, Ping Wei, Li Shao, Yaoyao Zhang, Le Qu,Tizhi Wu, Hongfeng Gu, Yan Zhao,Zhaoxing Chu,Qihua Zhu,Guangwei He, Yi Zou,Yungen Xu
Journal of medicinal chemistryno. 9 (2025): 9755-9776
Cited0Views0WOSBibtex
0
0
A Patent Review of Selective CDK9 Inhibitors in Treating Cancer
Tizhi Wu,Xiaowei Wu,Yifan Xu,Rui Chen,Jubo Wang,Zhiyu Li,Jinlei Bian
EXPERT OPINION ON THERAPEUTIC PATENTSno. 4 (2023): 309-322
Cited8Views0WOSBibtex
8
0
Author Statistics

#Papers: 10

#Citation: 127

H-Index: 6

G-Index: 7

Sociability: 4

Diversity: 1

Activity: 5

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn